Global Heart Transplantation Therapeutics Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	252 Pages	TechNavio	February, 2025	INF19659127

Best Price Guarantee
Price	from $2,500
Length	252 Pages
Publisher	TechNavio
Published Date	February, 2025
SKU	INF19659127

Heart Transplantation Therapeutics Market 2025-2029

The heart transplantation therapeutics market is forecasted to grow by USD 129.7 million during 2024-2029, accelerating at a CAGR of 3% during the forecast period. The report on the heart transplantation therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiovascular diseases and heart failures, availability of drugs in multiple dosage forms, and high dependency on immunosuppressants for heart transplantation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's heart transplantation therapeutics market is segmented as below:

By Drug Class

Immunosuppressants
Anti-infectives
Analgesics
Others

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Type

Left ventricular assist device (LVAD)
Heart transplantation
Implantable cardiac defibrillator (ICD)
Extracorporeal membrane oxygenation (ECMO)

By Indication

Ischemic heart disease (IHD)
Dilated cardiomyopathy (DCM)
Valvular heart disease (VHD)
Hypertrophic cardiomyopathy (HCM)

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing international collaborations for heart transplantation as one of the prime reasons driving the heart transplantation therapeutics market growth during the next few years. Also, advent of techniques for heart transplantation and growing awareness and accessibility regarding heart transplantation will lead to sizable demand in the market.

The report on the heart transplantation therapeutics market covers the following areas:

Heart Transplantation Therapeutics Market sizing
Heart Transplantation Therapeutics Market forecast
Heart Transplantation Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading heart transplantation therapeutics market vendors that include AbbVie Inc., Astellas Pharma Inc., Biocon Ltd., DR Reddys Laboratories Ltd., Endo International PLC, F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., LEO Pharma AS, Lupin Ltd., McKesson Corp., Novartis AG, Panacea Biotec Ltd., Pfizer Inc., RPG Enterprises, Strides Pharma Science Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the heart transplantation therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary - Data Table on Market Overview
  - Table Executive Summary - Data Table on Incremental Growth
Technavio Analysis
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Criticality of inputs and Factors of differentiation
- Factors of disruption
- Impact of drivers and challenges
Market Landscape
- Market ecosystem
  - Table Data Table on - Parent Market
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2024
- Market outlook: Forecast for 2024-2029
  - Table Data Table on Global - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Historic Market Size
- Global Heart Transplantation Therapeutics Market 2019 - 2023
  - Table Historic Market Size - Data Table on Global Heart Transplantation Therapeutics Market 2019 – 2023 ($ million)
- Drug Class segment analysis 2019 - 2023
- Distribution Channel segment analysis 2019 - 2023
- Type segment analysis 2019 - 2023
- Indication segment analysis 2019 - 2023
- Geography segment analysis 2019 - 2023
- Country segment analysis 2019 - 2023
Qualitative Analysis
- Impact of AI in global heart transplantation therapeutics market
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Drug Class
- Market segments
  - Table Data Table on Drug Class - Market share 2024-2029 (%)
- Comparison by Drug Class
  - Table Data Table on Comparison by Drug Class
- Immunosuppressants - Market size and forecast 2024-2029
  - Table Data Table on Immunosuppressants - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Immunosuppressants - Year-over-year growth 2024-2029 (%)
- Anti-infectives - Market size and forecast 2024-2029
  - Table Data Table on Anti-infectives - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Anti-infectives - Year-over-year growth 2024-2029 (%)
- Analgesics - Market size and forecast 2024-2029
  - Table Data Table on Analgesics - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Analgesics - Year-over-year growth 2024-2029 (%)
- Others - Market size and forecast 2024-2029
  - Table Data Table on Others - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Others - Year-over-year growth 2024-2029 (%)
- Market opportunity by Drug Class
  - Table Data Table on Market opportunity by Drug Class ($ million)
Market Segmentation by Distribution Channel
- Market segments
  - Table Data Table on Distribution Channel - Market share 2024-2029 (%)
- Comparison by Distribution Channel
  - Table Data Table on Comparison by Distribution Channel
- Hospital pharmacies - Market size and forecast 2024-2029
  - Table Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
- Retail pharmacies - Market size and forecast 2024-2029
  - Table Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
- Online pharmacies - Market size and forecast 2024-2029
  - Table Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
- Market opportunity by Distribution Channel
  - Table Data Table on Market opportunity by Distribution Channel ($ million)
Market Segmentation by Type
- Market segments
  - Table Data Table on Type - Market share 2024-2029 (%)
- Comparison by Type
  - Table Data Table on Comparison by Type
- Left ventricular assist device (LVAD) - Market size and forecast 2024-2029
  - Table Data Table on Left ventricular assist device (LVAD) - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Left ventricular assist device (LVAD) - Year-over-year growth 2024-2029 (%)
- Heart transplantation - Market size and forecast 2024-2029
  - Table Data Table on Heart transplantation - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Heart transplantation - Year-over-year growth 2024-2029 (%)
- Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029
  - Table Data Table on Implantable cardiac defibrillator (ICD) - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Implantable cardiac defibrillator (ICD) - Year-over-year growth 2024-2029 (%)
- Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024- 2029
  - Table Data Table on Extracorporeal membrane oxygenation (ECMO) - Market size and forecast 2024- 2029 ($ million)
  - Table Data Table on Extracorporeal membrane oxygenation (ECMO) - Year-over-year growth 2024-2029 (%)
- Market opportunity by Type
  - Table Data Table on Market opportunity by Type ($ million)
Market Segmentation by Indication
- Market segments
  - Table Data Table on Indication - Market share 2024-2029 (%)
- Comparison by Indication
  - Table Data Table on Comparison by Indication
- Ischemic heart disease (IHD) - Market size and forecast 2024-2029
  - Table Data Table on Ischemic heart disease (IHD) - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Ischemic heart disease (IHD) - Year-over-year growth 2024-2029 (%)
- Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029
  - Table Data Table on Dilated cardiomyopathy (DCM) - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Dilated cardiomyopathy (DCM) - Year-over-year growth 2024-2029 (%)
- Valvular heart disease (VHD) - Market size and forecast 2024-2029
  - Table Data Table on Valvular heart disease (VHD) - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Valvular heart disease (VHD) - Year-over-year growth 2024-2029 (%)
- Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029
  - Table Data Table on Hypertrophic cardiomyopathy (HCM) - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Hypertrophic cardiomyopathy (HCM) - Year-over-year growth 2024-2029 (%)
- Market opportunity by Indication
  - Table Data Table on Market opportunity by Indication ($ million)
Customer Landscape
- Customer landscape overview
Geographic Landscape
- Geographic segmentation
  - Table Data Table on Market share by geography 2024-2029 (%)
- Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2024-2029
  - Table Data Table on North America - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on North America - Year-over-year growth 2024-2029 (%)
- Europe - Market size and forecast 2024-2029
  - Table Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Asia - Market size and forecast 2024-2029
  - Table Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Rest of World (ROW) - Market size and forecast 2024-2029
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- US - Market size and forecast 2024-2029
  - Table Data Table on US - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on US - Year-over-year growth 2024-2029 (%)
- Germany - Market size and forecast 2024-2029
  - Table Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Germany - Year-over-year growth 2024-2029 (%)
- Canada - Market size and forecast 2024-2029
  - Table Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Canada - Year-over-year growth 2024-2029 (%)
- France - Market size and forecast 2024-2029
  - Table Data Table on France - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on France - Year-over-year growth 2024-2029 (%)
- Japan - Market size and forecast 2024-2029
  - Table Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Japan - Year-over-year growth 2024-2029 (%)
- UK - Market size and forecast 2024-2029
  - Table Data Table on UK - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on UK - Year-over-year growth 2024-2029 (%)
- India - Market size and forecast 2024-2029
  - Table Data Table on India - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on India - Year-over-year growth 2024-2029 (%)
- China - Market size and forecast 2024-2029
  - Table Data Table on China - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on China - Year-over-year growth 2024-2029 (%)
- South Korea - Market size and forecast 2024-2029
  - Table Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- Italy - Market size and forecast 2024-2029
  - Table Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Italy - Year-over-year growth 2024-2029 (%)
- Market opportunity by geography
  - Table Data Tables on Market opportunity by geography ($ million)
Drivers, Challenges, and Opportunity/Restraints
- Market drivers
  - Rising prevalence of cardiovascular diseases and heart failures
  - Availability of drugs in multiple dosage forms
  - High dependency on immunosuppressants for heart transplantation
- Market challenges
  - Adverse effects of immunosuppressants
  - Demand-supply imbalance for heart transplantation
  - Long-term complications associated with heart transplantation
- Impact of drivers and challenges
- Market opportunities/restraints
  - Growing international collaborations for heart transplantation
  - Advent of techniques for heart transplantation
  - Growing awareness and accessibility regarding heart transplantation
Competitive Landscape
- Overview
- Competitive Landscape
- Landscape disruption
- Industry risks
Competitive Analysis
- Companies profiled
- Company ranking index
- Market positioning of companies
- AbbVie Inc.
- Astellas Pharma Inc.
- Biocon Ltd.
- Dr Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Glenmark Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd.
- LEO Pharma AS
- Lupin Ltd.
- Novartis AG
- Panacea Biotec Ltd.
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Data procurement
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations